A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma
Document Type
Conference Proceeding
Publication Date
1-29-2024
Publication Title
Journal of Clinical Oncology
Abstract
2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA
Volume
42
Issue
4 Supplement
Recommended Citation
Pachynski, Russell Kent; Chatta, Gurkamal S.; Jain, Rohit K.; Moon, Helen H.; Sweis, Randy F.; Delacroix, Scott; Fang, Alana; D'amico, Leonard A.; Shaulov Kask, Angela; Fling, Steven P.; Lacroix, Andreanne; Kaiser, Judith; Sharon, Elad; and Yu, Evan Y., "A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma" (2024). School of Medicine Faculty Publications. 2834.
https://digitalscholar.lsuhsc.edu/som_facpubs/2834
10.1200/JCO.2024.42.4_suppl.628